Results per Page:
When it comes to cancer trials, what’s the (end)point?
New endpoint in multiple myeloma could mean faster drug approvals. Are more endpoint tweaks on the way?
Examining factors that may impact ovarian cancer survival disparities
From the Harris Group, Public Health Sciences Division
Genital powder use and epithelial ovarian cancer
From the Harris Group, Division of Public Health Sciences
What's new in breast cancer research: #SABCS19 edition
Fred Hutch researchers share long-term follow-up data on WHI hormone study, anti-hormone side-effect strategies and more at San Antonio meeting
Predicting ovarian cancer by counting tumor-attacking immune cells
Study led by Jason Bielas finds new way to quantify immune cells reliably, quickly and cheaply